Free
Erratum  |   February 2002
ERRATUM
Article Information
Erratum
Erratum   |   February 2002
ERRATUM
Anesthesiology 2 2002, Vol.96, 521. doi:
Anesthesiology 2 2002, Vol.96, 521. doi:
For the article by David J-S et al  . in the November 2001 issue of Anesthesiology (2001; 95:1226–33), the legends to figures 4 and 5were reversed. The legends should have appeared as follows:
Fig. 4. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of forskolin (50 μm). Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 6 in each group. *P  < 0.05 versus  baseline. P  values refer to between-groups differences. NS = not significant.
Fig. 4. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of forskolin (50 μm). Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 6 in each group. *P 
	< 0.05 versus 
	baseline. P 
	values refer to between-groups differences. NS = not significant.
Fig. 4. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of forskolin (50 μm). Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 6 in each group. *P  < 0.05 versus  baseline. P  values refer to between-groups differences. NS = not significant.
×
Fig. 5. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of dibutyryl 3′,5′-cAMP (0.5 mm) Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 8 in each group. *P  < 0.05 versus  baseline. P  values refer tobetween-groups differences. NS = not significant.
Fig. 5. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of dibutyryl 3′,5′-cAMP (0.5 mm) Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 8 in each group. *P 
	< 0.05 versus 
	baseline. P 
	values refer tobetween-groups differences. NS = not significant.
Fig. 5. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of dibutyryl 3′,5′-cAMP (0.5 mm) Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 8 in each group. *P  < 0.05 versus  baseline. P  values refer tobetween-groups differences. NS = not significant.
×
Fig. 4. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of forskolin (50 μm). Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 6 in each group. *P  < 0.05 versus  baseline. P  values refer to between-groups differences. NS = not significant.
Fig. 4. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of forskolin (50 μm). Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 6 in each group. *P 
	< 0.05 versus 
	baseline. P 
	values refer to between-groups differences. NS = not significant.
Fig. 4. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of forskolin (50 μm). Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 6 in each group. *P  < 0.05 versus  baseline. P  values refer to between-groups differences. NS = not significant.
×
Fig. 5. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of dibutyryl 3′,5′-cAMP (0.5 mm) Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 8 in each group. *P  < 0.05 versus  baseline. P  values refer tobetween-groups differences. NS = not significant.
Fig. 5. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of dibutyryl 3′,5′-cAMP (0.5 mm) Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 8 in each group. *P 
	< 0.05 versus 
	baseline. P 
	values refer tobetween-groups differences. NS = not significant.
Fig. 5. Effects of protamine (10 μg/ml) on the positive inotropic and lusitropic effects of dibutyryl 3′,5′-cAMP (0.5 mm) Vmax= maximum unloaded shortening velocity; AF = active isometric force; R1 = ratio of maximum shortening velocity to maximum lengthening velocity; R2 = ratio of the peak of the positive force derivative to the peak of the negative force derivative. Data are mean percentage of baseline ± SD; n = 8 in each group. *P  < 0.05 versus  baseline. P  values refer tobetween-groups differences. NS = not significant.
×